HbA1c measures how much sugar has permanently stuck to your red blood cells, giving a three-month average of glucose exposure. It needs no fasting and anchors both the diagnosis of diabetes and the tracking of long-term control.
Standard range versus optimal range
| Framework | HbA1c value | Source |
|---|---|---|
| Normal | below 5.7% | ADA Standards of Care |
| Prediabetes | 5.7-6.4% | ADA Standards of Care |
| Diabetes threshold | 6.5% and above, confirmed on repeat | ADA Standards of Care |
| Optimal for longevity | below about 5.4% | Cohort studies on cardiovascular risk |
When it runs high
A high HbA1c reflects weeks of elevated glucose and tracks the risk of eye, kidney, nerve and cardiovascular damage. Each one-point rise above normal adds meaningful risk, while each point lowered reduces microvascular complications substantially.
- Type 2 diabetes or insulin resistance
- Undiagnosed type 1 or LADA diabetes
- A variant hemoglobin that distorts the assay in some people
- Iron deficiency, which can falsely elevate the reading
- Recent transfusion or kidney disease, which can distort it either way
When it runs low
A low HbA1c usually reflects excellent glucose control, but values below about 4% can flag conditions that shorten red cell lifespan. In those cases the number underestimates true glucose exposure.
- Hemolytic anemia or recent blood loss
- Chronic kidney or liver disease altering red cell survival
- Recent transfusion
- Pregnancy, which lowers the value physiologically
- Excellent metabolic health, the common benign cause
A three-month glucose memory
Glucose sticks to hemoglobin for the entire 120-day life of a red blood cell, so the share of glycated cells mirrors average glucose exposure over that window. The test needs no fasting, shows little day-to-day noise, and predicts complications so well that it became both a diagnostic and a monitoring standard. An HbA1c of 6% corresponds to an average glucose near 126 mg/dL, and each point above adds roughly 30 mg/dL to the estimated average.
Cardiovascular risk starts below the diabetes line
The landmark Selvin analysis in the New England Journal of Medicine followed more than 11000 adults without diagnosed diabetes and found cardiovascular risk climbed steadily from an HbA1c of about 5% upward. That smooth curve is why longevity-minded clinicians aim for the low-normal zone rather than merely below 5.7%. The same smooth relationship holds for kidney disease and retinopathy.
When the number lies
Anything that changes red cell lifespan distorts HbA1c. Hemolysis and recent transfusion lower it, iron deficiency raises it, and some hemoglobin variants fool specific analyzers. When the HbA1c disagrees with fasting glucose or a glucose meter log, fructosamine or a continuous glucose monitor provides the tiebreaker.
Related calculators
Related biomarkers Glucose · Insulin · C-peptide